Home > Insider Trading > Filing (0001181431-10-058036)

Filing Details

Accession Number:: 0001181431-10-058036
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2010-11-29 21:47:14
Reporting Period:: 2010-11-29

Filing Date:: 2010-11-29
Accepted Time:: 2010-11-29 21:47:14
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1375151	Zogenix Inc.	ZGNX	Pharmaceutical Preparations (2834)	205300780

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1288238	Phd Arda Minocherhomjee	C/O Chicago Growth Partners Ii, L.p. 303 W. Madison Avenue, Suite 2500 Chicago IL 60606		Yes	No	Yes	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Acquisiton	2010-11-29	1,818,181	$0.00	1,818,181	No	4	C	Indirect	By Chicago Growth Partners II, L.P.
Common Stock	Acquisiton	2010-11-29	594,146	$0.00	2,412,327	No	4	C	Indirect	By Chicago Growth Partners II, L.P.
Common Stock	Acquisiton	2010-11-29	550,000	$4.00	2,962,327	No	4	P	Indirect	By Chicago Growth Partners II, L.P.

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	C	Indirect	By Chicago Growth Partners II, L.P.
No	4	C	Indirect	By Chicago Growth Partners II, L.P.
No	4	P	Indirect	By Chicago Growth Partners II, L.P.

Reported Derivative Transactions

Show Other Fields >>

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Common Stock	Series B Convertible Preferred Stock	Disposition	2010-11-29	18,181,818	$0.00	1,818,181	$0.00
Common Stock	8% Convertible Promissory Note	Disposition	2010-11-29	594,146	$0.00	594,146	$0.00

Remaning Holdings	Exercise Date	Expiration Date	Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
0			No	4	C	Indirect
0			No	4	C	Indirect

Footnotes

The Series B Convertible Preferred Stock automatically converted to Common Stock at the closing of the Issuer's initial public offering on Novenber 29, 2010 at a conversion ratio of one share of Common Stock for every ten shares of Series B Convertible Preferred Stock, rounded down to the next whole number, for no additional consideration.
These securities are held of record by Chicago Growth Partners II, L.P. ("CGP"). Chicago Growth Management II, LP ("CGM II LP") is the general partner of CGP, and Chicago Growth Management II, LLC ("CGM II LLC") is the general partner of CGM II LP. CGM II LLC and CGM II LP have shared voting and dispositive power of the shares held by CGP. The Reporting Person is a Managing Director of each of CGM II, LLC and CGM II, LP and as such has a proportionate pecuniary interest in such shares, but does not have sole voting or investment power with respect to such shares and disclaims beneficial ownership of these shares except to the extent of his pecuniary interest therein.
The principle of the Note and accrued interest thereon was automatically converted upon the closing of the Issuer's initial public offering on November 29, 2010 into shares of Common Stock at a conversion price equal to $4.00 per share, the per share price of the Common Stock sold in the Issuer's initial public offering.
The filing of this statement shall not be deemed an admission that, for the purposes of Section 16 of the Securities Exchange Act of 1934 or otherwise, the Reporting Person is the beneficial owner of equity securities covered by this statement.